ServicenavigationHauptnavigationTrailKarteikarten

Research unit
INNOSUISSE
Project number
125.999 IP-LS
Project title
Developing First-In-Class INPP5A Inhibitors as the First Effective Therapy for All GNAQ/11 Mutated Metastatic Uveal Melanoma Patients

Participants

Research organisation: Innosuisse
Swiss Innovation Agency
Einsteinstrasse 2
CH-3003 Bern
+41 58 461 61 61 (Call Center)
info@innosuisse.ch
www.innosuisse.ch/
Contact person

 Dzung Andreas
Universität Zürich

Scientific management
Universität Zürich